// COMPANY
Option Care
SECTOR HEALTHCAREMENTIONS 1LAST SEEN OCTOBER 6, 2026
// RECENT MENTIONS
// SIGNALS
1 SIGNAL
01
m_and_a·Axios Pro Rata·OCTOBER 6, 2026
“CD&R and McKesson (NYSE: MCK) agreed to buy medical infusion company Option Care (Nasdaq: OPCH) for $5.8b, or $32.05 per share (37% premium on yesterday's closing price).”
AI-extracted from podcast / newsletter / paper summaries. May contain errors.